from NNLX: ".....That being said, it must be n
Post# of 9122
from NNLX: ".....That being said, it must be noted that if NanoLogix was a
standard, well-financed company with millions of dollars in reserve, the work on
the N-Assay and other products would have been fully funded by the company
and the technology would potentially be a part of current market technology
choices and ideally making a market impact as the BEST available diagnostic.
As NanoLogix does not have that as a reserve, it takes longer to accomplish
the same goal............